In a patient with a remote cholecystectomy who now has elevated transaminases, negative abdominal ultrasound, CT abdomen, and MRCP, and bacteremia, could a common bile duct stone have already passed?

Yes, a passed common bile duct stone is the most likely explanation for this clinical presentation

In a patient with remote cholecystectomy presenting with transaminitis, bacteremia, and negative imaging (US, CT, MRCP), a spontaneously passed CBD stone is highly probable and explains all findings. This scenario represents a well-documented phenomenon where stones pass into the duodenum before or between imaging studies.

Clinical Reasoning

Why This Diagnosis Fits

The combination of:

• Transaminitis (indicating recent biliary obstruction)
• Bacteremia (consistent with recent cholangitis from transient obstruction)
• Negative imaging (stone already passed)
• Remote cholecystectomy (doesn't prevent recurrent choledocholithiasis)

This constellation strongly suggests a stone that caused transient obstruction with ascending infection, then spontaneously passed before definitive imaging could capture it 1.

Evidence for Spontaneous Stone Passage

Studies confirm that stones frequently pass spontaneously before or after cholecystectomy 1. Recent data shows that 25.2% of patients with CBDS confirmed on MRCP had no stones at subsequent ERCP, indicating spontaneous passage 2. Predictors of spontaneous passage include:

• Smaller stone size
• Distal stone location
• Single stones
• Longer interval between imaging and intervention
• Greater decrease in ALT levels 2

Post-Cholecystectomy Choledocholithiasis

Choledocholithiasis can occur decades after cholecystectomy 3, 4, 5. Cases have been reported 30-60 years post-cholecystectomy 3, 5. The absence of a gallbladder does NOT eliminate risk of CBD stones, which can form de novo in the bile duct (primary stones) or represent retained/recurrent secondary stones 1.

Diagnostic Limitations

Why Imaging May Miss Stones

Normal US, CT, and MRCP do NOT exclude CBDS if clinical suspicion remains high 1, 6. Key limitations:

• Small stones (<4mm) are frequently missed by MRCP 7
• Distal CBD stones and stones impacted at the papilla are particularly difficult to visualize 7
• Timing matters: A stone present during symptom onset may have passed by the time imaging is performed 2

The Role of EUS

If clinical suspicion persists despite negative MRCP, endoscopic ultrasound (EUS) should be strongly considered 7. EUS has superior sensitivity (98.51%) compared to MRCP (55.22%) for detecting CBD stones, especially small ones 7. In your case with bacteremia and transaminitis, EUS could identify any remaining stones or sludge that MRCP missed.

Management Approach

Immediate Considerations

1. Treat the bacteremia and presumed cholangitis with appropriate antibiotics
2. Monitor liver enzymes closely: A declining trend in ALT/AST supports spontaneous stone passage 2
3. Consider ERCP if:
   • Clinical deterioration occurs
   • Persistent biliary obstruction (rising bilirubin, persistent pain)
   • Failure to improve with antibiotics 1

Risk Stratification

This patient had HIGH-risk features for CBDS 1:

• Transaminitis
• Bacteremia (suggesting cholangitis)
• Remote cholecystectomy doesn't lower risk

Per guidelines, high-risk patients warrant direct ERCP 1. However, if the patient is improving clinically with declining transaminases, the stone has likely passed and ERCP may be unnecessary 2.

Follow-up Strategy

If the patient improves without intervention:

• Confirm normalization of liver enzymes
• Repeat imaging (US) in 4-6 weeks to assess CBD diameter
• Low threshold for EUS or ERCP if symptoms recur 3, 4

Critical Pitfalls to Avoid

1. Don't dismiss biliary pathology in post-cholecystectomy patients: Choledocholithiasis remains possible decades after surgery 3, 4, 5

2. Don't rely solely on negative MRCP: Profound transaminitis (>1000 IU/L) with bacteremia demands consideration of pancreaticobiliary causes even with negative imaging 4

3. Don't delay ERCP if cholangitis persists: Patients with cholangitis who fail to respond to antibiotics or have septic shock require urgent biliary decompression 1

4. Consider recurrence risk: Patients with dilated CBD, multiple prior episodes, and remote cholecystectomy have higher risk of recurrent stones 3

Natural History Context

The GallRiks study showed that 25.3% of patients with untreated CBDS experienced unfavorable outcomes (pancreatitis, cholangitis, obstruction) versus 12.7% with stone extraction 1. However, this applies to documented stones. In your case, if the stone has passed and the patient is improving, the immediate risk has resolved—but recurrence risk remains 3.